A Comparison of Life Events in Adolescents with Major Depression, Borderline Personality Disorder and Matched Controls: A Pilot Study

2008 ◽  
Vol 41 (5) ◽  
pp. 300-306 ◽  
Author(s):  
Netta Horesh ◽  
Sharon Ratner ◽  
Nathaniel Laor ◽  
Paz Toren
Keyword(s):  
Borderline Personality Disorder ◽  
Pilot Study ◽  
Major Depression ◽  
Personality Disorder ◽  
Life Events ◽  
Borderline Personality

Relationship between coping with negative life-events and psychopathology: Major depression and borderline personality disorder

2009 ◽  
Vol 82 (4) ◽  
pp. 421-425 ◽  
Author(s):  
Katja Wingenfeld ◽  
Christoph Mensebach ◽  
Nina Rullkoetter ◽  
Nicole Schlosser ◽  
Camille Schaffrath ◽  
...  
Keyword(s):  
Borderline Personality Disorder ◽  
Major Depression ◽  
Personality Disorder ◽  
Life Events ◽  
Negative Life Events ◽  
Borderline Personality

Central Autonomic Network Association With Cardiac Autonomic Sleep-Wake Rhythm in Major Depression and Borderline Personality Disorder

2021 ◽  
Vol 89 (9) ◽  
pp. S385
Author(s):  
Agustina Wainsztein ◽  
Camacho Vicente ◽  
Carolina Abulafia ◽  
Mirta F. Villarreal ◽  
Carles Soriano-Mas ◽  
...  
Keyword(s):  
Borderline Personality Disorder ◽  
Major Depression ◽  
Personality Disorder ◽  
Borderline Personality ◽  
Central Autonomic Network

Associations of childhood trauma, trauma in adulthood and previous-year stress with psychopathology in patients with major depression and borderline personality disorder

2011 ◽  
Vol 35 (8) ◽  
pp. 647-654 ◽  
Author(s):  
Katja Wingenfeld ◽  
Camille Schaffrath ◽  
Nina Rullkoetter ◽  
Christoph Mensebach ◽  
Nicole Schlosser ◽  
...  
Keyword(s):  
Borderline Personality Disorder ◽  
Major Depression ◽  
Personality Disorder ◽  
Childhood Trauma ◽  
Borderline Personality

scholarly journals Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability

2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Silvio Bellino ◽  
Paola Bozzatello ◽  
Camilla Rinaldi ◽  
Filippo Bogetto
Keyword(s):  
Borderline Personality Disorder ◽  
Pilot Study ◽  
Personality Disorder ◽  
Adverse Events ◽  
Mechanism Of Action ◽  
Severity Index ◽  
Borderline Personality ◽  
Controlled Trials ◽  
Efficacy And Safety ◽  
Dsm Iv

Antipsychotics are recommended for the treatment of impulsive dyscontrol and cognitive perceptual symptoms of borderline personality disorder (BPD). Three reports supported the efficacy of oral risperidone on BPD psychopathology. Paliperidone ER is the metabolite of risperidone with a similar mechanism of action, and its osmotic release reduces plasmatic fluctuations and antidopaminergic effects. The aim of this study is to evaluate efficacy and safety of paliperidone ER in BPD patients. 18 outpatients with a DSM-IV-TR diagnosis of BPD were treated for 12 weeks with paliperidone ER (3–6 mg/day). They were assessed at baseline, week 4, and week 12, using the CGI-Severity item, the BPRS, the HDRS, the HARS, the SOFAS, the BPD Severity Index (BPDSI), and the Barratt Impulsiveness Scale (BIS-11). Adverse events were evaluated with the DOTES. Paliperidone ER was shown to be effective and well tolerated in reducing severity of global symptomatology and specific BPD symptoms, such as impulsive dyscontrol, anger, and cognitive-perceptual disturbances. Results need to be replicated in controlled trials.

Sign in / Sign up

Export Citation Format

Share Document